Ask the Experts: Meningococcal B: Vaccine Safety

Results (1)

In clinical trials and in postlicensure safety surveillance, the most common local adverse events within 7 days of receiving MenB were injection site pain, swelling or redness and the most common systemic symptoms were headache, fatigue and body aches. In general, these types of self-limited reactions are reported more frequently than with MenACWY vaccination.

Last reviewed: November 15, 2024

This page was updated on .